Skip to main content
Top
Published in: Current Gastroenterology Reports 9/2021

01-09-2021 | Nutrition | Nutrition and Obesity (S McClave and E Omer, Section Editors)

Fiber in the ICU: Should it Be a Regular Part of Feeding?

Authors: Caitlin H. Green, Rebecca A. Busch, Jayshil J. Patel

Published in: Current Gastroenterology Reports | Issue 9/2021

Login to get access

Abstract

Purpose of Review

To highlight the controversy of fiber use in the current critical care nutrition guidelines; review the effect of fiber on the gut microbiota in the critically ill; and examine the data on fiber and outcomes in the intensive care setting.

Recent Findings

Fiber is increasingly recognized as a necessary component of colonic health and nutrition support. In critical illness there is a shift toward gut dysbiosis and immune dysregulation. Through fermentation and the generation of short-chain fatty acids, fiber has a role in maintaining intestinal homeostasis, immune function, and supporting commensal bacteria. In contrast to fermentable fiber, recent animal models suggest that non-fermentable fiber can also favorably alter intestinal homeostasis in a mechanism distinct from short chain fatty acids. In the critically ill, RCTs and meta-analyses suggest that soluble and mixed fiber supplemented enteral nutrition can reduce diarrhea and is well tolerated. Based on limited data, there may be benefits in reducing length of hospital stay, certain infections, and glucose metabolism. Nonetheless, the role of fiber enriched nutrition in critically ill patients is controversial as evident in the conflicting guidelines.

Summary

Despite shortcomings in the literature, soluble and mixed fiber supplemented enteral nutrition is safe and beneficial in most hemodynamically stable intensive care patients. More research is necessary to determine optimal fiber composition.
Literature
1.
go back to reference O’Keefe SJ. The need to reassess dietary fiber requirements in healthy and critically ill patients. Gastroenterol Clin N Am. 2018;47(1):219–29.CrossRef O’Keefe SJ. The need to reassess dietary fiber requirements in healthy and critically ill patients. Gastroenterol Clin N Am. 2018;47(1):219–29.CrossRef
2.
go back to reference Dahl WJ, Agro NC, Eliasson AM, Mialki KL, Olivera JD, Rusch CT, et al. Health benefits of fiber fermentation. J Am Coll Nutr. 2017;36(2):127–36.PubMedCrossRef Dahl WJ, Agro NC, Eliasson AM, Mialki KL, Olivera JD, Rusch CT, et al. Health benefits of fiber fermentation. J Am Coll Nutr. 2017;36(2):127–36.PubMedCrossRef
3.
go back to reference Cho SS, Qi L, Fahey GC, Klurfield DM. Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease. Am J Clin Nutr. 2013;98(2):594–619.PubMedCrossRef Cho SS, Qi L, Fahey GC, Klurfield DM. Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease. Am J Clin Nutr. 2013;98(2):594–619.PubMedCrossRef
4.
go back to reference Crowe FL, Balkwill A, Cairns BJ, Appleby PN, Green J, Reeves GK, et al. Source of dietary fibre and diverticular disease incidence: a prospective study of UK women. Gut. 2014;63:1450–6.PubMedCrossRef Crowe FL, Balkwill A, Cairns BJ, Appleby PN, Green J, Reeves GK, et al. Source of dietary fibre and diverticular disease incidence: a prospective study of UK women. Gut. 2014;63:1450–6.PubMedCrossRef
5.
go back to reference Liu X, Wu Y, Li F, Zhang D. Dietary fiber intake reduces risk of inflammatory bowel disease: result from a meta-analysis. Nutr Res. 2015;35:753–8.PubMedCrossRef Liu X, Wu Y, Li F, Zhang D. Dietary fiber intake reduces risk of inflammatory bowel disease: result from a meta-analysis. Nutr Res. 2015;35:753–8.PubMedCrossRef
6.
go back to reference Brahe LK, Astrup A, Larsen LH. Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic disease? Obes Rev. 2013;14(12):950–9.PubMedCrossRef Brahe LK, Astrup A, Larsen LH. Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic disease? Obes Rev. 2013;14(12):950–9.PubMedCrossRef
7.
go back to reference Frazier TH, DiBaise JK, McClain CJ. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J Parenter Enteral Nutr. 2011;35(5 Suppl):14S–20S.PubMedCrossRef Frazier TH, DiBaise JK, McClain CJ. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J Parenter Enteral Nutr. 2011;35(5 Suppl):14S–20S.PubMedCrossRef
10.
go back to reference Whelan K, Judd PA, Preedy VR, Simmering R, Jann A, Taylor MA. Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans. J Nutr. 2005;135(8):1896–902.PubMedCrossRef Whelan K, Judd PA, Preedy VR, Simmering R, Jann A, Taylor MA. Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans. J Nutr. 2005;135(8):1896–902.PubMedCrossRef
11.
go back to reference Schneider SM, Le Gall P, Girard-Pipau F, Piche T, Pompei A, Nano JL, et al. Total artificial nutrition is associated with major changes in the fecal flora. Eur J Nutr. 2000;39(6):248–55.PubMedCrossRef Schneider SM, Le Gall P, Girard-Pipau F, Piche T, Pompei A, Nano JL, et al. Total artificial nutrition is associated with major changes in the fecal flora. Eur J Nutr. 2000;39(6):248–55.PubMedCrossRef
12.
go back to reference • Mcclave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine (SCCM) and American Society for Parental and Enteral Nutrition (A.S.P.E.N). JPEN J Parenter Enteral Nutr. 2016;40(2):159–211 The most recent ASPEN/SCCM guidelines on critical care nutrition, which recommend a fermentable soluble fiber additive for all hemodynamically stable MICU/SICU patients receiving enteral nutrition. They also recommend against routine use of a mixed fiber formula in the critically ill to prevent diarrhea, as well as the use of soluble or insoluble fiber in patients at high risk for bowel ischemia or severe dysmotility.PubMedCrossRef • Mcclave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine (SCCM) and American Society for Parental and Enteral Nutrition (A.S.P.E.N). JPEN J Parenter Enteral Nutr. 2016;40(2):159–211 The most recent ASPEN/SCCM guidelines on critical care nutrition, which recommend a fermentable soluble fiber additive for all hemodynamically stable MICU/SICU patients receiving enteral nutrition. They also recommend against routine use of a mixed fiber formula in the critically ill to prevent diarrhea, as well as the use of soluble or insoluble fiber in patients at high risk for bowel ischemia or severe dysmotility.PubMedCrossRef
13.
go back to reference Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38:48–79.PubMedCrossRef Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38:48–79.PubMedCrossRef
14.
go back to reference Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr. 2003;27(5):355–73.PubMedCrossRef Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr. 2003;27(5):355–73.PubMedCrossRef
16.
go back to reference McDonald D, Ackermann G, Khailova L, Heyland D, Kozar R, Lemieux M, et al. Extreme dysbiosis of the microbiome in critical illness. mSphere. 2016;1(4):e00199–16.PubMedPubMedCentralCrossRef McDonald D, Ackermann G, Khailova L, Heyland D, Kozar R, Lemieux M, et al. Extreme dysbiosis of the microbiome in critical illness. mSphere. 2016;1(4):e00199–16.PubMedPubMedCentralCrossRef
17.
go back to reference Yamada T, Shimizu K, Ogura H, Asahara T, Nomoto K, Yamakawa K, et al. Rapid and sustained long-term decrease of fecal short-chain fatty acids in critically ill patients with systemic inflammatory response syndrome. JPEN J Parenter Enteral Nutr. 2015;39(5):569–77.PubMedCrossRef Yamada T, Shimizu K, Ogura H, Asahara T, Nomoto K, Yamakawa K, et al. Rapid and sustained long-term decrease of fecal short-chain fatty acids in critically ill patients with systemic inflammatory response syndrome. JPEN J Parenter Enteral Nutr. 2015;39(5):569–77.PubMedCrossRef
18.
go back to reference Bouhnik Y, Vahedi K, Achour L, Attar A, Salfati J, Pochart P, et al. Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. J Nutr. 1999;129(1):113–6.PubMedCrossRef Bouhnik Y, Vahedi K, Achour L, Attar A, Salfati J, Pochart P, et al. Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. J Nutr. 1999;129(1):113–6.PubMedCrossRef
19.
go back to reference •• Morowitz MJ, Di Caro V, Pang D, Cummings J, Firek B, Rogers MN, et al. Dietary supplementation with nonfermentable fiber alters the gut microbiota and confers protection in murine models of sepsis. Crit Care Med. 2017;45(5):e516–23 An animal model demonstrating that a non-fermentable fiber can favorably alter the gut microbiome and improve outcomes in a model of sepsis.PubMedPubMedCentralCrossRef •• Morowitz MJ, Di Caro V, Pang D, Cummings J, Firek B, Rogers MN, et al. Dietary supplementation with nonfermentable fiber alters the gut microbiota and confers protection in murine models of sepsis. Crit Care Med. 2017;45(5):e516–23 An animal model demonstrating that a non-fermentable fiber can favorably alter the gut microbiome and improve outcomes in a model of sepsis.PubMedPubMedCentralCrossRef
20.
go back to reference Venegas-Borsellino C, Kwon M. Impact of soluble fiber in the microbiome and outcomes in critically ill patients. Curr Nutr Rep. 2019;8(4):347–55.PubMedCrossRef Venegas-Borsellino C, Kwon M. Impact of soluble fiber in the microbiome and outcomes in critically ill patients. Curr Nutr Rep. 2019;8(4):347–55.PubMedCrossRef
21.
go back to reference •• Reis AMD, Fruchtenicht AV, Loss SH, Moreira LF. Use of dietary fibers in enteral nutrition of critically ill patients: a systematic review. Rev Bras Ter Intensiva. 2018;30(3):358–65 A large, recent systematic review evaluating the use and safety of soluble and mixed fibers in the enteral nutrition of critically ill patients.PubMedPubMedCentralCrossRef •• Reis AMD, Fruchtenicht AV, Loss SH, Moreira LF. Use of dietary fibers in enteral nutrition of critically ill patients: a systematic review. Rev Bras Ter Intensiva. 2018;30(3):358–65 A large, recent systematic review evaluating the use and safety of soluble and mixed fibers in the enteral nutrition of critically ill patients.PubMedPubMedCentralCrossRef
22.
go back to reference Heimburger DC, Sockwell DG, Geels WJ. Diarrhea with enteral feeding: prospective reappraisal of putative causes. Nutrition. 1994;10(5):392–6.PubMed Heimburger DC, Sockwell DG, Geels WJ. Diarrhea with enteral feeding: prospective reappraisal of putative causes. Nutrition. 1994;10(5):392–6.PubMed
23.
go back to reference Whelan K, Judd PA, Tuohy KM, Gibson GR, Preedy VR, Taylor MA. Fecal microbiota in patients receiving enteral feeding are highly variable and may be altered in those who develop diarrhea. Am J Clin Nutr. 2009;89(1):240–7.PubMedCrossRef Whelan K, Judd PA, Tuohy KM, Gibson GR, Preedy VR, Taylor MA. Fecal microbiota in patients receiving enteral feeding are highly variable and may be altered in those who develop diarrhea. Am J Clin Nutr. 2009;89(1):240–7.PubMedCrossRef
24.
go back to reference Bleichner G. Ble ́haut H, Mentec H, Moyse D. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Med. 1997;23:517–23.PubMedCrossRef Bleichner G. Ble ́haut H, Mentec H, Moyse D. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Med. 1997;23:517–23.PubMedCrossRef
25.
go back to reference Thibault R, Graf S, Clerc A, Delieuvin N, Heidegger CP, Pichard C. Diarrhoea in the ICU: respective contribution of feeding and antibiotics. Crit Care. 2013;17(4):R153.PubMedPubMedCentralCrossRef Thibault R, Graf S, Clerc A, Delieuvin N, Heidegger CP, Pichard C. Diarrhoea in the ICU: respective contribution of feeding and antibiotics. Crit Care. 2013;17(4):R153.PubMedPubMedCentralCrossRef
26.
go back to reference Guenter PA, Settle RG, Perlmutter S, Marino PL, DeSimone GA, Rolandelli RH. Tube feeding-related diarrhea in acutely ill patients. JPEN J Parenter Enteral Nutr. 1991;15(3):277–80.PubMedCrossRef Guenter PA, Settle RG, Perlmutter S, Marino PL, DeSimone GA, Rolandelli RH. Tube feeding-related diarrhea in acutely ill patients. JPEN J Parenter Enteral Nutr. 1991;15(3):277–80.PubMedCrossRef
27.
go back to reference Elia M, Engfer MB, Green CJ, Silk DB. Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae. Aliment Pharmacol Ther. 2008;27(2):120–45.PubMedCrossRef Elia M, Engfer MB, Green CJ, Silk DB. Systematic review and meta-analysis: the clinical and physiological effects of fibre-containing enteral formulae. Aliment Pharmacol Ther. 2008;27(2):120–45.PubMedCrossRef
28.
go back to reference Spapen H, Diltoer M, Van Malderen C, Opdenacker G, Suys E, Huyghens L. Soluble fiber reduces the incidence of diarrhea in septic patients receiving total enteral nutrition: a prospective, double-blind, randomized, and controlled trial. Clin Nutr. 2001;20(4):301–5.PubMedCrossRef Spapen H, Diltoer M, Van Malderen C, Opdenacker G, Suys E, Huyghens L. Soluble fiber reduces the incidence of diarrhea in septic patients receiving total enteral nutrition: a prospective, double-blind, randomized, and controlled trial. Clin Nutr. 2001;20(4):301–5.PubMedCrossRef
29.
go back to reference •• Yagmurdur H, Leblebici F. Enteral nutrition preference in critical care: fibre-enriched or fibre-free? Asia Pac J Clin Nutr. 2016;25(4):740–6 A large RCT of mechanically ventilated ICU patients receiving mixed fiber supplemented EN demonstrated better efficiency of EN based on volume ratio, and less diarrhea compared to the fiber-free control group.PubMed •• Yagmurdur H, Leblebici F. Enteral nutrition preference in critical care: fibre-enriched or fibre-free? Asia Pac J Clin Nutr. 2016;25(4):740–6 A large RCT of mechanically ventilated ICU patients receiving mixed fiber supplemented EN demonstrated better efficiency of EN based on volume ratio, and less diarrhea compared to the fiber-free control group.PubMed
30.
go back to reference Jack L, Coyer F, Courtney M, Venkatesh B. Probiotics and diarrhoea management in enterally tube fed critically ill patients-what is the evidence? Intensive Crit Care Nurs. 2010;26:314–26.PubMedCrossRef Jack L, Coyer F, Courtney M, Venkatesh B. Probiotics and diarrhoea management in enterally tube fed critically ill patients-what is the evidence? Intensive Crit Care Nurs. 2010;26:314–26.PubMedCrossRef
31.
go back to reference Yang G, Wu XT, Zhou Y, Wang YL. Application of dietary fiber in clinical enteral nutrition: a meta-analysis of randomized controlled trials. World J Gastroenterol. 2005;11(25):3935–8.PubMedPubMedCentralCrossRef Yang G, Wu XT, Zhou Y, Wang YL. Application of dietary fiber in clinical enteral nutrition: a meta-analysis of randomized controlled trials. World J Gastroenterol. 2005;11(25):3935–8.PubMedPubMedCentralCrossRef
32.
go back to reference Zhao R, Wang Y, Huang Y, Cui Y, Xia L, Rao Z, et al. Effects of fiber and probiotics on diarrhea associated with enteral nutrition in gastric cancer patients: A prospective randomized and controlled trial. Medicine. 2017;96(43):e8418.PubMedPubMedCentralCrossRef Zhao R, Wang Y, Huang Y, Cui Y, Xia L, Rao Z, et al. Effects of fiber and probiotics on diarrhea associated with enteral nutrition in gastric cancer patients: A prospective randomized and controlled trial. Medicine. 2017;96(43):e8418.PubMedPubMedCentralCrossRef
35.
go back to reference Chittawatanarat K, Pokawinpudisnun P, Polbhakdee Y. Mixed fibers diet in surgical ICU septic patients. Asia Pac J Clin Nutr. 2010;19(4):458–64.PubMed Chittawatanarat K, Pokawinpudisnun P, Polbhakdee Y. Mixed fibers diet in surgical ICU septic patients. Asia Pac J Clin Nutr. 2010;19(4):458–64.PubMed
37.
go back to reference Rushdi TA, Pichard C, Khater YH. Control of diarrhea by fiber-enriched diet in ICU patients on enteral nutrition: a prospective randomized controlled trial. Clin Nutr. 2004;23(6):1344–52.PubMedCrossRef Rushdi TA, Pichard C, Khater YH. Control of diarrhea by fiber-enriched diet in ICU patients on enteral nutrition: a prospective randomized controlled trial. Clin Nutr. 2004;23(6):1344–52.PubMedCrossRef
40.
go back to reference Frankenfield DC, Beyer PL. Soy-polysaccharide fiber: effect on diarrhea in tube-fed, head-injured patients. Am J Clin Nutr. 1989;50(3):533–8.PubMedCrossRef Frankenfield DC, Beyer PL. Soy-polysaccharide fiber: effect on diarrhea in tube-fed, head-injured patients. Am J Clin Nutr. 1989;50(3):533–8.PubMedCrossRef
41.
go back to reference • Tuncay P, Arpaci F, Doganay M, Erdem D, Sahna A, Ergun H, et al. Use of standard enteral formula versus enteric formula with prebiotic content in nutrition therapy: a randomized controlled study among neuro-critical care patients. Clin Nutr ESPEN. 2018;25:26–36 In a RCT of neuro-critical care patients, prebiotic/fiber supplemented EN was associated with significantly fewer enteral feeding related complications including lower rates of diarrhea and faster resolution of diarrhea, as well as less insulin use and lower CRP levels, compared to standard EN.PubMedCrossRef • Tuncay P, Arpaci F, Doganay M, Erdem D, Sahna A, Ergun H, et al. Use of standard enteral formula versus enteric formula with prebiotic content in nutrition therapy: a randomized controlled study among neuro-critical care patients. Clin Nutr ESPEN. 2018;25:26–36 In a RCT of neuro-critical care patients, prebiotic/fiber supplemented EN was associated with significantly fewer enteral feeding related complications including lower rates of diarrhea and faster resolution of diarrhea, as well as less insulin use and lower CRP levels, compared to standard EN.PubMedCrossRef
42.
go back to reference Homann HH, Kemen M, Fuessenich C, Senkal M, Zumtobel V. Reduction in diarrhea incidence by soluble fiber in patients receiving total or supplemental enteral nutrition. JPEN J Parenter Entral Nutr. 1994;18(6):486–90.CrossRef Homann HH, Kemen M, Fuessenich C, Senkal M, Zumtobel V. Reduction in diarrhea incidence by soluble fiber in patients receiving total or supplemental enteral nutrition. JPEN J Parenter Entral Nutr. 1994;18(6):486–90.CrossRef
43.
go back to reference Schultz AA, Ashby-Hughes B, Taylor R, Gillis DE, Wilkins M. Effects of pectin on diarrhea in critically ill tube-fed patients receiving antibiotics. Am J Crit Care. 2000;9(6):403–11.PubMedCrossRef Schultz AA, Ashby-Hughes B, Taylor R, Gillis DE, Wilkins M. Effects of pectin on diarrhea in critically ill tube-fed patients receiving antibiotics. Am J Crit Care. 2000;9(6):403–11.PubMedCrossRef
44.
go back to reference del Olmo D, Lopez del Val T, Martinez de Icaya P, et al. La fibre en nutricion enteral: revision sistematica de la literatura. Nutr Hosp. 2004;19(3):167–74.PubMed del Olmo D, Lopez del Val T, Martinez de Icaya P, et al. La fibre en nutricion enteral: revision sistematica de la literatura. Nutr Hosp. 2004;19(3):167–74.PubMed
45.
go back to reference Karakan T, Ergun M, Dogan I, Cindoruk M, Unal S. Comparison of early enteral nutrition in severe acute pancreatitis with prebiotic fiber supplementation versus standard enteral solution: a prospective randomized double-blind study. World J Gastroenterol. 2007;13(19):2733–7.PubMedPubMedCentralCrossRef Karakan T, Ergun M, Dogan I, Cindoruk M, Unal S. Comparison of early enteral nutrition in severe acute pancreatitis with prebiotic fiber supplementation versus standard enteral solution: a prospective randomized double-blind study. World J Gastroenterol. 2007;13(19):2733–7.PubMedPubMedCentralCrossRef
46.
go back to reference Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of pancreatitis. Am J Gastroenterol. 2013;108(9):1400–15.PubMedCrossRef Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of pancreatitis. Am J Gastroenterol. 2013;108(9):1400–15.PubMedCrossRef
47.
go back to reference McClave SA. Factors that worsen disease severity in acute pancreatitis: implications for more innovative nutrition therapy. Nutr Clin Pract. 2019;34(supp 1):S43–8.PubMedCrossRef McClave SA. Factors that worsen disease severity in acute pancreatitis: implications for more innovative nutrition therapy. Nutr Clin Pract. 2019;34(supp 1):S43–8.PubMedCrossRef
48.
go back to reference Petrov MS, van Santvoort HC, Besselink MG, van der Heijden GJ, Windsor JA, Gooszen HG. Enteral nutrition and the risk of mortality and infectious complications in patients with severe acute pancreatitis: a meta-analysis of randomized trials. Arch Surg. 2008;143:1111–7.PubMedCrossRef Petrov MS, van Santvoort HC, Besselink MG, van der Heijden GJ, Windsor JA, Gooszen HG. Enteral nutrition and the risk of mortality and infectious complications in patients with severe acute pancreatitis: a meta-analysis of randomized trials. Arch Surg. 2008;143:1111–7.PubMedCrossRef
49.
go back to reference Cao Y, Xu Y, Lu T, Gao F, Mo Z. Meta-analysis of enteral nutrition versus total parenteral nutrition in patients with severe acute pancreatitis. Ann Nutr Metab. 2008;53(3–4):268–75.PubMedCrossRef Cao Y, Xu Y, Lu T, Gao F, Mo Z. Meta-analysis of enteral nutrition versus total parenteral nutrition in patients with severe acute pancreatitis. Ann Nutr Metab. 2008;53(3–4):268–75.PubMedCrossRef
50.
go back to reference Yi F, Ge L, Zhao J, Lei Y, Zhou F, Chen Z, et al. Meta-analysis: total parenteral nutrition versus total enteral nutrition in predicted severe acute pancreatitis. Intern Med. 2012;51(6):523–30.PubMedCrossRef Yi F, Ge L, Zhao J, Lei Y, Zhou F, Chen Z, et al. Meta-analysis: total parenteral nutrition versus total enteral nutrition in predicted severe acute pancreatitis. Intern Med. 2012;51(6):523–30.PubMedCrossRef
51.
go back to reference Caparros T, Lopez J, Grau T. Early enteral nutrition in critically ill patients with a high-protein diet enriched with arginine, fiber, and antioxidants compared with a standard high-protein diet. The effect on nosocomial infections and outcome. J Parenter Enter Nutr. 2001;25(6):299–309.CrossRef Caparros T, Lopez J, Grau T. Early enteral nutrition in critically ill patients with a high-protein diet enriched with arginine, fiber, and antioxidants compared with a standard high-protein diet. The effect on nosocomial infections and outcome. J Parenter Enter Nutr. 2001;25(6):299–309.CrossRef
52.
go back to reference Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469(7331):543–7.PubMedCrossRef Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469(7331):543–7.PubMedCrossRef
53.
go back to reference May T, Mackie RI, Fahey GC, Cremin JC, Garleb KA. Effect of fiber source on short-chain fatty acid production and on the growth and toxin production by Clostridium difficile. Scand J Gastroenterol. 1994;29(10):916–22.PubMedCrossRef May T, Mackie RI, Fahey GC, Cremin JC, Garleb KA. Effect of fiber source on short-chain fatty acid production and on the growth and toxin production by Clostridium difficile. Scand J Gastroenterol. 1994;29(10):916–22.PubMedCrossRef
54.
go back to reference Roychowdhury S, Cadnum J, Glueck B, Obrenovich M, Donskey C, Cresci G. Faecalibacterium prausnitzii and a prebiotic protect intestinal health in a mouse model of antibiotic and clostridium difficile exposure. J Parenter Enter Nutr. 2018;42(7):1156–67.CrossRef Roychowdhury S, Cadnum J, Glueck B, Obrenovich M, Donskey C, Cresci G. Faecalibacterium prausnitzii and a prebiotic protect intestinal health in a mouse model of antibiotic and clostridium difficile exposure. J Parenter Enter Nutr. 2018;42(7):1156–67.CrossRef
55.
go back to reference •• Di Caro V, Alcamo A, Cummings J, Clark R, Novak EA, Mollen KP, et al. Effect of dietary cellulose supplementation on gut barrier function and apoptosis in a murine model of endotoxemia. PLoS One. 2019;14(12):e0224838. https://doi.org/10.1371/journal.pone.0224838 Dietary cellulose, a non-fermentable fiber, decreased LPS-mediated intestinal hyperpermeability by its effect on tight junction proteins, as well as decreased apoptosis and increased epithelial cell proliferation in a mouse model of endotoxemia.CrossRefPubMedPubMedCentral •• Di Caro V, Alcamo A, Cummings J, Clark R, Novak EA, Mollen KP, et al. Effect of dietary cellulose supplementation on gut barrier function and apoptosis in a murine model of endotoxemia. PLoS One. 2019;14(12):e0224838. https://​doi.​org/​10.​1371/​journal.​pone.​0224838 Dietary cellulose, a non-fermentable fiber, decreased LPS-mediated intestinal hyperpermeability by its effect on tight junction proteins, as well as decreased apoptosis and increased epithelial cell proliferation in a mouse model of endotoxemia.CrossRefPubMedPubMedCentral
56.
go back to reference Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J Parenter Enter Nutr. 2007;31(2):119–26.CrossRef Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J Parenter Enter Nutr. 2007;31(2):119–26.CrossRef
57.
go back to reference Lewis S, Burmeister S, Brazier J. Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study. Clin Gastroenterol Hepatol. 2005;3(5):442–8.PubMedCrossRef Lewis S, Burmeister S, Brazier J. Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study. Clin Gastroenterol Hepatol. 2005;3(5):442–8.PubMedCrossRef
58.
go back to reference Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.PubMedCrossRef Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.PubMedCrossRef
59.
go back to reference Simakachorn N, Bibiloni R, Yimyaem P, Tongpenyai Y, Varavithaya W, Grathwohl D, et al. Tolerance, safety, and effect on the faecal microbiota of an enteral formula supplemented with pre- and probiotics in critically ill children. J Pediatr Gastroenterol Nutr. 2011;53(2):174–81.PubMedCrossRef Simakachorn N, Bibiloni R, Yimyaem P, Tongpenyai Y, Varavithaya W, Grathwohl D, et al. Tolerance, safety, and effect on the faecal microbiota of an enteral formula supplemented with pre- and probiotics in critically ill children. J Pediatr Gastroenterol Nutr. 2011;53(2):174–81.PubMedCrossRef
60.
go back to reference McClave SA, Chang WK. Feeding the hypotensive patient: does enteral feeding precipitate or protect against ischemic bowel? Nutr Clin Pract. 2003;18(4):279–84.PubMedCrossRef McClave SA, Chang WK. Feeding the hypotensive patient: does enteral feeding precipitate or protect against ischemic bowel? Nutr Clin Pract. 2003;18(4):279–84.PubMedCrossRef
61.
go back to reference Scaife CL, Saffle JR, Morris SE. Intestinal obstruction secondary to enteral feeding in burn trauma patients. J Trauma. 1999;47(5):859–63.PubMedCrossRef Scaife CL, Saffle JR, Morris SE. Intestinal obstruction secondary to enteral feeding in burn trauma patients. J Trauma. 1999;47(5):859–63.PubMedCrossRef
62.
go back to reference McIvor AC, Meguid MM, Curtas S, Warren J, Kaplan DS. Intestinal obstruction from cecal bezoar; a complication of fiber-containing tube feedings. Nutrition. 1990;6(1):115–7.PubMed McIvor AC, Meguid MM, Curtas S, Warren J, Kaplan DS. Intestinal obstruction from cecal bezoar; a complication of fiber-containing tube feedings. Nutrition. 1990;6(1):115–7.PubMed
63.
64.
go back to reference Wang F, Schwarz BT, Graham WV, Wang Y, Su L, Clayburgh DR, et al. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology. 2006;131(4):1153–63.PubMedCrossRef Wang F, Schwarz BT, Graham WV, Wang Y, Su L, Clayburgh DR, et al. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology. 2006;131(4):1153–63.PubMedCrossRef
65.
go back to reference Ralls MW, Demehri FR, Feng Y, Woods Ignatoski KM, Teitelbaum DH. Enteral nutrient deprivation in patients leads to a loss of intestinal epithelial barrier function. Surgery. 2015;157(4):732–42.PubMedCrossRef Ralls MW, Demehri FR, Feng Y, Woods Ignatoski KM, Teitelbaum DH. Enteral nutrient deprivation in patients leads to a loss of intestinal epithelial barrier function. Surgery. 2015;157(4):732–42.PubMedCrossRef
66.
go back to reference Feng Y, Teitelbaum DH. Tumour necrosis factor--induced loss of intestinal barrier function requires TNFR1 and TNFR2 signaling in a mouse model of total parenteral nutrition. J Physiol. 2013;591(15):3709–23.PubMedPubMedCentralCrossRef Feng Y, Teitelbaum DH. Tumour necrosis factor--induced loss of intestinal barrier function requires TNFR1 and TNFR2 signaling in a mouse model of total parenteral nutrition. J Physiol. 2013;591(15):3709–23.PubMedPubMedCentralCrossRef
67.
go back to reference Demehri FR, Krug SM, Feng Y, Lee IF, Schulzke JD, Teitelbaum DH. Tight junction ultrastructure alterations in a mouse model of enteral nutrient deprivation. Dig Dis Sci. 2016;61(6):1524–33.PubMedCrossRef Demehri FR, Krug SM, Feng Y, Lee IF, Schulzke JD, Teitelbaum DH. Tight junction ultrastructure alterations in a mouse model of enteral nutrient deprivation. Dig Dis Sci. 2016;61(6):1524–33.PubMedCrossRef
68.
go back to reference Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock. 2007;28(4):384–93.PubMedPubMedCentralCrossRef Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock. 2007;28(4):384–93.PubMedPubMedCentralCrossRef
70.
go back to reference Patel JJ, Rice T, Heyland D. Safety and Outcomes of Early Enteral Nutrition in Circulatory Shock. JPEN J Parenter Enteral Nutr. 2020;44(5):779–84.PubMedCrossRef Patel JJ, Rice T, Heyland D. Safety and Outcomes of Early Enteral Nutrition in Circulatory Shock. JPEN J Parenter Enteral Nutr. 2020;44(5):779–84.PubMedCrossRef
71.
go back to reference Schorghuber M, Fruhwald S. Effects of enteral nutrition on gastrointestinal function in patients who are critically ill. Lancet Gastroenterol Hepatol. 2018;3(4):281–7.PubMedCrossRef Schorghuber M, Fruhwald S. Effects of enteral nutrition on gastrointestinal function in patients who are critically ill. Lancet Gastroenterol Hepatol. 2018;3(4):281–7.PubMedCrossRef
72.
go back to reference Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371(9613):651–9.PubMedCrossRef Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371(9613):651–9.PubMedCrossRef
73.
go back to reference McClave SA, Martindale RG. Why do current strategies for optimal nutritional therapy neglect the microbiome? Nutrition. 2019;60:100–5.PubMedCrossRef McClave SA, Martindale RG. Why do current strategies for optimal nutritional therapy neglect the microbiome? Nutrition. 2019;60:100–5.PubMedCrossRef
Metadata
Title
Fiber in the ICU: Should it Be a Regular Part of Feeding?
Authors
Caitlin H. Green
Rebecca A. Busch
Jayshil J. Patel
Publication date
01-09-2021
Publisher
Springer US
Published in
Current Gastroenterology Reports / Issue 9/2021
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-021-00814-5